Is ACRYLAMIDE safe in cosmetics?
ACRYLAMIDE has a safety rating of "MODERATE" in our database. EU status: restricted. US status: restricted. 10 toxicological study endpoint(s) are available in our database.
Also known as: 2-Propenamide, Acrylagel, Amresco Acryl-40, BRN 0605349, EINECS 201-173-7 (+8 more)
ACRYLAMIDE (CAS 79-06-1) is a cosmetic cosmetic ingredient functioning as Not Reported. NOAEL 0.5 mg/kg bw/day (cross-referenced against ToxValDB ECHA IUCLID); EU Regulation 1223/2009 status: restricted, max II/681; GHS signal word DANGER. Industrial safety data is also available in the chemical safety database. Same-CAS public records also appear in industrial chemical safety and pharmaceutical data.
View industrial chemical safety profile for CAS 79-06-1 →
ACRYLAMIDE is classified GHS Danger (H301, H312, H315, H317, H319, H332, H340, H350) in the chemicals database but is restricted in EU cosmetics at max II/681.
Source: Cosmetics: ingredients.eu_status/eu_max; Chemicals: ghs_classifications.signal_word/hazard_statement_code
For full compliance data across multiple jurisdictions, use the Substance Compliance tool.
Margin of Safety, dermal absorption, and sensitization profile summaries for ACRYLAMIDE.
Calculate MoS for your specific formulation with the MoS Calculator.
10 study endpoints found for ACRYLAMIDE. NOAEL (No Observed Adverse Effect Level) values are used to calculate the Margin of Safety per SCCS methodology.
| Endpoint | Value | Route | Species | Study Type | Source |
|---|---|---|---|---|---|
| NOAEL | =0.00023 mg/kg bw/day | - | Rat | Toxicology study | INCHEM_WHO_jecfa_jecmono_v63je01 |
| NOAEL | =0.00023 mg/kg bw/day | - | Rat | Toxicology study | INCHEM_WHO_jecfa_jecmono_v63je01 |
| NOAEL | =0.003 mg/kg bw/day | oral | - | Toxicology study | INCHEM_WHO_jecfa_jecmono_v63je01 |
| NOAEL | =0.003 mg/kg bw/day | oral | - | Toxicology study | INCHEM_WHO_jecfa_jecmono_v63je01 |
| NOAEL | =0.00428571428571429 mg/kg bw/day | - | - | Toxicology study | INCHEM_WHO_jecfa_jecmono_v63je01 |
| NOAEL | =0.00428571428571429 mg/kg bw/day | - | - | Toxicology study | INCHEM_WHO_jecfa_jecmono_v63je01 |
| NOAEL | =0.006 mg/kg bw/day | - | - | Toxicology study | INCHEM_WHO_jecfa_jecmono_v63je01 |
| NOAEL | =0.006 mg/kg bw/day | - | - | Toxicology study | INCHEM_WHO_jecfa_jecmono_v63je01 |
| NOAEL | =0.088 mg/kg bw/day | oral | - | Toxicology study | INCHEM_WHO_jecfa_jecmono_v63je01 |
| NOAEL | =0.088 mg/kg bw/day | oral | - | Toxicology study | INCHEM_WHO_jecfa_jecmono_v63je01 |
Globally Harmonized System classification per ECHA C&L inventory and ILO/WHO International Chemical Safety Cards.
Pre-calculated NOAEL → SED → MoS audit trail for ACRYLAMIDE across SCCS product categories, with measured dermal absorption where available.
10 toxicity values from EPA ToxValDB (aggregated from CCTE, HPV, ToxRefDB, IRIS, and other regulatory dossiers).
| Endpoint | Value | Species | Route | Duration | Source |
|---|---|---|---|---|---|
| cancer slope factor | =4.5 (mg/kg-day)-1 | Human | inhalation | chronic | Cal OEHHA |
| cancer slope factor | =4.5 (mg/kg-day)-1 | Human | oral | chronic | Cal OEHHA |
| LOEL | =0.05 mg/kg-day | Rat | oral | short-term | ECOTOX |
| LOEL | =10 mg/kg-day | Rat | oral | short-term | ECOTOX |
| LOEL | =5 mg/kg-day | Rat | oral | short-term | ECOTOX |
| MRL | =0.01 mg/kg-day | Human | oral | - | ATSDR MRLs |
| MRL | =0.001 mg/kg-day | Human | oral | - | ATSDR MRLs |
| MRL | =0.001 mg/kg-day | Human | oral | - | ATSDR MRLs |
| LOEL | =1.05 mg/kg-day | Mouse | oral | chronic | WHO JECFA Tox Studies |
| NOAEL | =0.67 mg/kg-day | Rat | oral | chronic | WHO JECFA Tox Studies |
International Agency for Research on Cancer (WHO) monograph evaluation.
NB Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data
Legally binding harmonized classification per Regulation (EC) No 1272/2008 (CLP) Annex VI.
Inserted via ATP: CLP00
European Chemicals Agency REACH dossier and Substances of Very High Concern listing.
European Commission CosIng database Annex references per Regulation (EC) No 1223/2009.
Additional regulatory detail beyond the 7-jurisdiction summary: Saudi SFDA, Korea MFDS, ASEAN ACD, Japan/Korea, Brazil/India, and cross-jurisdictional restriction entries.
| Jurisdiction | Status | Max % | Product Type |
|---|---|---|---|
| BR | banned | - | Trace: rinse-off products 0.1 mg/kg residual; others 0.5 mg/kg |
| CA | banned | - | - |
Safety and regulatory annotations from PubChem (NCBI) aggregated sources.
Expert safety assessment and concern-level summary for ACRYLAMIDE.
Public NOAEL study rows linked to ACRYLAMIDE by CAS number or substance name.
Same-CAS public records found in pharmaceutical data.
Same-CAS rows from the pharmaceutical spoke database.
ACRYLAMIDE has a safety rating of "MODERATE" in our database. EU status: restricted. US status: restricted. 10 toxicological study endpoint(s) are available in our database.
ACRYLAMIDE EU regulatory status: restricted. Maximum allowed concentration: II/681. This is based on EU Regulation 1223/2009 and its amendments.
ACRYLAMIDE functions as: Not Reported. It is classified as a cosmetic ingredient in our database. CAS number: 79-06-1.
The NOAEL (No Observed Adverse Effect Level) for ACRYLAMIDE is =0.00023 mg/kg bw/day based on a Toxicology study study via oral route in Rat. A total of 10 study endpoints are available. Source: INCHEM_WHO_jecfa_jecmono_v63je01.
ACRYLAMIDE carries a GHS signal word of "DANGER". Hazard statements: Toxic if swallowed Harmful in contact with skin or if inhaled Causes skin irritation Causes serious eye irritation May cause an allergic skin reaction May cause genetic defects May cause cancer Suspected of damaging fertility or the unborn child Causes damage to nervous system Causes damage to the nervous system through prolonged or repeated exposure. This classification is based on the ILO/WHO International Chemical Safety Card and ECHA C&L inventory data. Note: GHS classification applies to the pure substance — at cosmetic use concentrations, hazard thresholds may not be met.
ACRYLAMIDE also appears in industrial chemical safety and pharmaceutical data. The cross-vertical cards on this page render same-CAS public rows from the matched databases.
ACRYLAMIDE is classified GHS Danger (H301, H312, H315, H317, H319, H332, H340, H350) in the chemicals database but is restricted in EU cosmetics at max II/681.
Check ACRYLAMIDE compliance across multiple jurisdictions:
Scan any product label with Piro — our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.
Try Piro Free →Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for ACRYLAMIDE in your formulation.